We did not find any significant association between FGFR alterations and clinico-pathologic data such as age, gender, size or location of the tumor (right-sided vs. left-sided), lymph node or distant metastases, microsatellite instability, KRAS mutation and overall survival in primary tumors. This evidence concerns the gene KRAS and neoplasm.